Breed-Associated Differences in Differential Gene Expression Following Immunotherapy-Based Treatment of Canine High-Grade Glioma
Canine high-grade glioma (HGG) is among the deadliest and most treatment-resistant forms of canine cancer. Successful, widespread treatment is challenged by heterogeneity in tumor cells and the tumor microenvironment and tumor evolution following treatment. Immunotherapy is theoretically a strong no...
Saved in:
| Main Authors: | Susan A. Arnold, Walter C. Low, Grace Elizabeth Pluhar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Animals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2615/15/1/28 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy yields breed-specific worst survival outcomes among three investigated therapies in French bulldogs with high-grade glioma
by: Susan A. Arnold, et al.
Published: (2025-03-01) -
DSN1 may predict poor prognosis of lower-grade glioma patients and be a potential target for immunotherapy
by: Yulong Jia, et al.
Published: (2024-12-01) -
Dabrafenib plus trametinib in low-grade versus high-grade gliomas: a systematic review and meta-analysis
by: Bardia Hajikarimloo, et al.
Published: (2024-11-01) -
Immunology and prospects of immunotherapy against malignant gliomas: humoral immunity
by: S. A. Kulyova, et al.
Published: (2021-12-01) -
Expression of toll-like receptors and inflammatory mediators in primary human glioma cells (low- and high-grade) compared to primary cells from epileptic human brain
by: Negin Masoomabadi, et al.
Published: (2025-09-01)